Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism
Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism In Patients Undergoing Major Lung or Abdominal Surgery
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Terminated
Poor recruitment
Other terminated trials from McGill University Health Centre/Research Institute of the McGill University Health Centre
Other Insulin Resistance trials with similar outcome
Listed as NCT02393573, this NA trial focuses on Insulin Resistance and Major Lung or Abdominal Surgery and remains terminated or withdrawn. Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Oct 2019 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Oct 2019 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Medtronic - MITG
- Mitacs
For direct contact, visit the study record on ClinicalTrials.gov .